Volkhart Min-Jian Li

This inventor holds 55 USPTO granted patents and 22 published patent applications, plus 8 CIPO patents and 30 EPO patents, primarily in Pharmaceutical Chemistry (CPC class A61K). Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Adverio Pharma Gmbh. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Volkhart Min-Jian Li. Retrieved from https://idiyas.com/inventor/volkhart-min-jian-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 55 (Patent Applications = 22)

% Patents Active = 45.5

CIPO Patents = 8 (Patent Applications = 5)

EPO Patents = 30 (Patent Applications = 52)

Average Co-Inventor Count = 10.3

ph-index = 12

Forward Citations = 416(Granted Patents)

Forward Citations (Not Self Cited) = 291(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

25 out of 721

Bayer Intellectual Property Gmbh

patents

20 out of 387

Bayer Pharma Aktiengesellschaft

Bayer Healthcare Aktiengesellschaft

patents

5. 2 out of 192

Bayer Schering Pharma Ag

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Pyrazolopyridines

Imidazopyridines

Phenylpropionic Acid Derivatives

Amino-Substituted Compounds

Heterocycles

Carboxylic Acid Derivatives

Triazolo Compounds

ALK1 Inhibitors

COPD Treatment

Bicyclic Aza Heterocycles

Fluoroalkyl Compounds

Cardiovascular Diseases

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064429 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2024-08-20),

2. 11439642 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2022-09-13),

3. 11377417 - Branched 3-phenylpropionic acid derivatives and their use (2022-07-05),

4. 10736896 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2020-08-11),

5. 10662185 - Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use (2020-05-26),

6. 10292970 - Heteroaryl-substituted imidazo[1,2-A]pyridines and their use (2019-05-21),

7. 10259776 - Branched 3-phenylpropionic acid derivatives and their use (2019-04-16),

8. 10174021 - Substituted pyrazolo[1,5-A]pyridines and their use (2019-01-08),

9. 10052312 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2018-08-21),

10. 10023528 - Branched 3-phenylpropionic acid derivatives and their use (2018-07-17),

11. 9993476 - Substituted 5-flouro-1H-pyrazolopyridines and their use (2018-06-12),

12. 9884063 - Amido-substituted azole compounds (2018-02-06),

13. 9776997 - 3-aryl-substituted imidazo[1,2-A]pyridines and their use (2017-10-03),

14. 9771360 - Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use (2017-09-26),

15. 9688699 - 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines (2017-06-27),

Title: Volkhart Min-Jian Li: A Pioneer in Medicinal Chemistry

Introduction

Volkhart Min-Jian Li is a distinguished inventor based in Velbert, Germany, with an impressive portfolio of 55 patents to his name. His extensive work in the field of medicinal chemistry has significantly contributed to advancements in treating various diseases, particularly cardiovascular disorders.

Latest Patents

Among his latest innovations are patents related to substituted 5-fluoro-1H-pyrazolopyridines. These novel compounds have been developed for their potential use in the treatment and prophylaxis of diseases. The applications detail processes for their preparation and outline various therapeutic uses, emphasizing their role in creating medicaments aimed at cardiovascular health.

Career Highlights

Volkhart has honed his expertise through his tenure at Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His engagement with these leading companies in the pharmaceutical sector has enabled him to further his research and development efforts, driving innovation in drug discovery and formulation.

Collaborations

Throughout his career, Volkhart has collaborated with notable colleagues, including Johannes-Peter Stasch and Frank Wunder. These partnerships have likely enriched his research endeavors and fostered a collaborative environment that is crucial in the field of medicinal research.

Conclusion

Volkhart Min-Jian Li stands out as a key figure in the realm of medicinal chemistry, with a focus on developing novel therapeutic agents. His significant contributions through numerous patents not only represent his dedication to innovation but also his commitment to enhancing healthcare through scientific advancements.

Profile summary based on public USPTO records.